Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc ICOTF


Primary Symbol: T.MSCL Alternate Symbol(s):  MSCLF

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).


TSX:MSCL - Post by User

Comment by regardlesson Jul 31, 2018 12:13pm
78 Views
Post# 28391892

RE:way oversold, this is going green today and next days :)

RE:way oversold, this is going green today and next days :)I’m not entirely opposed to the oversold comment because it’s partially true...
but im interested in the pharmokenetic data ....once that’s digested you can talk about a partner or any wild bull spit imagination idea a lot of you have...
this stockwill be between 8cent and 21cent range for the foreseeable future unless a wildcard can happen here
still a good stock to go long on now even if it means going long for a payday of 5-10cents a share if you bought at 10cents recently 
hard to argue with the positive here....
also I got a mlot message this morning from a poster here and it was about how immune imnp raised 18million$ not long ago...
even if their stock is in the dumps doesn’t mean they can’t come up with the money they owe us and it shows they can raise money when needed.
<< Previous
Bullboard Posts
Next >>